Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 17 Jun 2021 00:30 CEST |
ARGENX SE | argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology | 20103010 Biotechnology | Other subject |
| 07 Jun 2021 07:00 CEST |
ARGENX SE | argenx to regain global rights to cusatuzumab | 20103010 Biotechnology | Other subject |
| 01 Jun 2021 10:01 CEST |
ARGENX SE | argenx Appoints Karl Gubitz as Chief Financial Officer | 20103010 Biotechnology | Other subject |
| 01 Jun 2021 07:00 CEST |
ARGENX SE | argenx to Present at Upcoming Investor Conferences | 20103010 Biotechnology | Other subject |
| 14 May 2021 07:00 CEST |
ARGENX SE | argenx Reports First Quarter 2021 Financial Results and Provides Business Update | 20103010 Biotechnology | Other subject |
| 11 May 2021 11:00 CEST |
ARGENX SE | argenx announces results of Annual General Meeting of Shareholders | 20103010 Biotechnology | Other subject |
| 07 May 2021 07:00 CEST |
ARGENX SE | argenx to Report First Quarter 2021 Financial Results and Business Update on May 14, 2021 | 20103010 Biotechnology | Other subject |